Novartis explains stance over India patent law challenge

Article Date: 27/02/2012 08:00
Novartis explains stance over India patent law challenge

Vacancy Search

Quick job search

Advanced Search

Latest News

Last chance to enter PT Marketer of the Year

Last chance to enter PT Marketer of the Year

Upcoming events: Pivotal data for Seattle Genetics and Erytech

Welcome to your weekly digest of approaching regulatory and clinical readouts. By October, Seattle Genetics will reveal interim data from a phase III trial called Aethera, testing Adcetris...

Europe okays Novo Nordisk diabetes combo Xultophy

Europe okays Novo Nordisk diabetes combo Xultophy

Lilly's Cyramza shows survival benefit in gastro cancers

Lilly's Cyramza shows survival benefit in gastro cancers

FDA OKs fast-action erectile dysfunction drug Stendra

FDA OKs fast-action erectile dysfunction drug Stendra

Pharma needs to engage more digitally with docs

Pharma needs to engage more digitally with docs

Bayer pharma R&D spend to rise after plastics spin-off

Bayer pharma R&D spend to rise after plastics spin-off

BLOG: What does the Apple Watch mean for healthcare?

BLOG: What does the Apple Watch mean for healthcare?

ABPI backs NICE call to review NHS adoption of new drugs

ABPI backs NICE call to review NHS adoption of new drugs

NICE urges new approach to how NHS adopts new drugs

NICE urges new approach to how NHS adopts new drugs
more news